Substance / Medication

Fluvastatin

Overview

Active Ingredient
fluvastatin
RxNorm CUI
41127

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Clinical Trials

20 trials linked to this intervention

20
Total Trials
0
Recruiting
10
With Results

Research Evidence

Published studies and systematic reviews

Sort:
Associations between,andand lipid-lowering efficacy and pharmacokinetics of fluvastatin: a meta-analysis.
Zhang Zi Hao, Yue Sun Li Chao, Gu Hong Yan et al. · Pharmacogenomics · 2023
PMID: 37318060Meta-Analysis
Effect of Fluvastatin on Cardiovascular Complications in Kidney Transplant Patients: A Systemic Review and Meta-analysis.
Hwang Seun Deuk, Lee Jin Ho, Jhee Jong Hyun et al. · Transplant Proc · 2019
PMID: 31447193Meta-Analysis
Fluvastatin for lowering lipids.
Adams Stephen P, Sekhon Sarpreet S, Tsang Michael et al. · Cochrane Database Syst Rev · 2018
PMID: 29508377Meta-AnalysisFull text (PMC)
The association between the SLCO1B1, apolipoprotein E, and CYP2C9 genes and lipid response to fluvastatin: a meta-analysis.
Xiang Qian, Zhang Xiaodan, Ma Lingyue et al. · Pharmacogenet Genomics · 2018
PMID: 30363031Meta-Analysis
Fluvastatin reduces cardiac mortality in patients with coronary heart disease.
Ballantyne Christie M, Riegger Günter, Moore Nicholas et al. · Cardiovasc Drugs Ther · 2004
PMID: 15115905Meta-Analysis
Lack of pharmacokinetic interaction between fluvastatin and green tea in healthy volunteers.
Misaka Shingen, Abe Osamu, Sato Hideyuki et al. · Eur J Clin Pharmacol · 2018
PMID: 29368187RCT
Impaired endothelial function and arterial stiffness in patients with type 2 diabetes - The effect of a very low-dose combination of fluvastatin and valsartan.
Boncelj Svetek Maja, Eržen Barbara, Kanc Karin et al. · J Diabetes Complications · 2017
PMID: 28012835RCT

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Fluvastatin (substance)
SNOMED CT
387585004
UMLS CUI
C0082608
RxNorm CUI
41127

Clinical Data

This intervention maps to 4 entities in the Healos knowledge graph.

4
Conditions
0
Biomarkers
0
Specialists
0
Symptoms
20
Clinical Trials

Data is sourced from SNOMED CT, UMLS, and the Healos clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.